Envoy Medical, Inc. announced the termination of its At-The-Market (ATM) Equity Facility, effective June 24, 2026. This facility had previously authorized the company to offer and sell up to $15 million worth of its common stock. The company states that this termination reflects its confidence in its current capital position. The ATM Agreement was originally entered into on January 17, 2025.